Axsome Therapeutics, Inc. (NASDAQ:AXSM) Shares Bought by

4 days ago · JPMorgan Chase & Co. lifted its position in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM - Free Report) by 14.9% in the third quarter, according to its most recent …

9%
OFF

Axsome Therapeutics, Inc. (NASDAQ:AXSM) Shares Bought By

2 weeks from now

4 days ago · JPMorgan Chase & Co. lifted its position in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM - Free Report) by 14.9% in the third quarter, according to its most recent …

marketbeat.com

7%
OFF

Axsome Therapeutics, Inc. (NASDAQ:AXSM) Shares Acquired By

2 weeks from now

Dec 10, 2024 · BNP Paribas Financial Markets raised its position in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM - Free Report) by 71.7% during the 3rd quarter, according …

marketbeat.com

7%
OFF

Axsome Therapeutics, Inc. (NASDAQ:AXSM) Shares Bought By BNP …

2 weeks from now

Dec 10, 2024 · BNP Paribas Financial Markets lifted its holdings in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 71.7% during the third quarter, …

americanbankingnews.com

5%
OFF

Axsome (AXSM) Moves 11.5% Higher: Will This Strength Last?

2 weeks from now

9 hours ago · Axsome Therapeutics (AXSM) shares ended the last trading session 11.5% higher at $89.27. The jump came on an impressive volume with a higher-than-average number of …

yahoo.com

$1.34
OFF

Axsome Therapeutics (AXSM) Stock Price, News & Analysis

2 weeks from now

4 days ago · Axsome Therapeutics, Inc. (NASDAQ:AXSM) released its quarterly earnings results on Tuesday, November, 12th. The company reported ($1.34) EPS for the quarter, topping the …

marketbeat.com

$125.00
OFF

Axsome Therapeutics (AXSM) Gets A Buy From TD Cowen

2 weeks from now

13 hours ago · In a report released today, Joseph Thome from TD Cowen maintained a Buy rating on Axsome Therapeutics (AXSM – Research Report), with a price target of $125.00. The …

businessinsider.com

$89.27
OFF

Needham & Company LLC Reiterates “Buy” Rating For Axsome …

2 weeks from now

23 hours ago · Shares of NASDAQ AXSM opened at $89.27 on Monday. The business has a fifty day simple moving average of $92.21 and a 200 day simple moving average of $89.22. The …

etfdailynews.com

$140
OFF

Axsome Therapeutics Price Target Raised To $140 From $138 At RBC ...

2 weeks from now

Jan 7, 2025 · RBC Capital raised the firm’s price target on Axsome Therapeutics (AXSM) to $140 from $138 and keeps an Outperform rating on the shares as part of a broader research note …

nasdaq.com

5%
OFF

Axsome (AXSM) Moves 11.5% Higher: Will This Strength Last?

2 weeks from now

23 hours ago · Axsome Therapeutics (AXSM Quick Quote AXSM - Free Report) shares ended the last trading session 11.5% higher at $89.27. The jump came on an impressive volume with a …

zacks.com

$92
OFF

Axsome Therapeutics Provides Preliminary Fourth Quarter And Full …

2 weeks from now

1 day ago · Auvelity preliminary 4Q and full year 2024 net product sales of $92.6 million and $291.4 million, respectively Sunosi preliminary 4Q and full year 2024 net product revenue of …

businessinsider.com

3%
OFF

Axsome Therapeutics (NASDAQ:AXSM) Stock Price Up 5.3% On

2 weeks from now

1 day ago · Axsome Therapeutics, Inc. (NASDAQ:AXSM - Get Free Report)'s share price rose 5.3% during trading on Monday after Truist Financial raised their price target on the stock from …

marketbeat.com

$25
OFF

Axsome Therapeutics Provides Preliminary Fourth Quarter And Full …

2 weeks from now

1 day ago · Sunosi preliminary 4Q and full year 2024 net product revenue of $25.7 million and $93.8 million, respectively. NEW YORK, Jan. 13, 2025 (GLOBE NEWSWIRE) — Axsome …

financialpost.com

$64.11
OFF

Axsome Therapeutics' (AXSM) "Buy" Rating Reaffirmed At …

2 weeks from now

1 day ago · Axsome Therapeutics has a 12 month low of $64.11 and a 12 month high of $105.00. The company has a quick ratio of 2.37, a current ratio of 2.44 and a debt-to-equity ratio of …

marketbeat.com

$1.34
OFF

Truist Financial Forecasts Strong Price Appreciation For Axsome ...

2 weeks from now

1 day ago · Axsome Therapeutics (NASDAQ:AXSM - Get Free Report) last issued its quarterly earnings results on Tuesday, November 12th. The company reported ($1.34) earnings per …

marketbeat.com

$239.24
OFF

Axsome Therapeutics (AXSM) Earnings Date And Reports 2025

2 weeks from now

Most Bought Stocks; Members of Congress; Corporate Events. Corporate Buybacks; Economic Reports; ... Axsome Therapeutics (NASDAQ:AXSM) has a recorded net income of -$239.24 …

marketbeat.com

5%
OFF

Axsome (AXSM) Moves 11.5% Higher: Will This Strength Last?

2 weeks from now

Axsome Therapeutics (AXSM) shares ended the last trading session 11.5% higher at $89.27. The jump came on an impressive volume with a higher-than-average number of shares changing …

nasdaq.com

FAQs about Axsome Therapeutics, Inc. (NASDAQ:AXSM) Shares Bought by Coupon?

How much did Axsome Therapeutics (axsm) raise?

Axsome Therapeutics (AXSM) raised $52 million in an initial public offering on Thursday, November 19th 2015. The company issued 4,300,000 shares at a price of $11.00-$13.00 per share. Ladenburg Thalmann and Cantor Fitzgerald & Co. served as the underwriters for the IPO and Brean Capital was co-manager. ...

Where can I buy Axsome Therapeutics stock?

Shares of AXSM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Axsome Therapeutics own? ...

Should you buy Axsome Therapeutics (axsm – research report)?

In a report released today, Joseph Thome from TD Cowen maintained a Buy rating on Axsome Therapeutics (AXSM – Research Report), with a price target of $125.00. The company’s shares closed yesterday at $89.27. According to TipRanks, Thome is an analyst with an average return of -5.0% and a 37.95% success rate. ...

Who is Axsome Therapeutics (axsm)?

Begin your TipRanks Premium journey today. Axsome Therapeutics (AXSM) Company Description: Axsome Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel therapies for the management of central nervous system disorders. ...

How did Axsome Therapeutics perform compared to last year?

Based on Axsome Therapeutics’ latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $104.76 million and a GAAP net loss of $64.6 million. In comparison, last year the company earned a revenue of $57.79 million and had a GAAP net loss of $62.2 million ...

When is Axsome Therapeutics's next earnings report?

Axsome Therapeutics has confirmed that its next quarterly earnings report will be published on Monday, August 7th, 2023. Axsome Therapeutics will be holding an earnings conference call on Monday, August 7th at 8:00 AM Eastern. Interested parties can register for or listen to the call.. When is Axsome Therapeutics's earnings date? ...